Epigenomics AG
Financial ratios & Valuation

Historical Multiples (2013 – 2021)

2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-46.33-0.51-0.70-0.69-0.75-0.69-0.71-1.17-11.59-3.66-0.72
Price/Sales ratio
216.253.003.031.834.155.7410.7516.354.5346.882.99
Price/Book Value ratio
53.160.740.890.530.730.471.253.561.271.900.63
Price/Cash Flow ratio
-52.79-0.62-0.77-0.58-0.80-0.85-0.89-1.43-6.77-2.95-0.82
Price/Free Cash Flow ratio
-52.63-0.55-0.75-0.53-0.76-0.84-0.88-1.43-6.72-2.78-0.80
Price/Earnings Growth ratio
-0.90-0.110.03-0.140.03-0.04N/A0.020.13-0.01-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
69.33%51.49%43.56%61.10%86.80%71.29%77.51%82.77%97.80%75.83%79.05%
Operating Profit Margin
-458.94%-556.27%-444.95%-293.07%-551.98%-841.16%-1304.26%-1380.87%-38.01%-1270.54%-696.57%
Pretax Profit Margin
-458.24%-589.31%-444.23%-292.69%-560.56%-876.06%-1294.75%-1385.15%-38.85%-1278.30%-718.31%
Net Profit Margin
-466.68%-587.52%-431.55%-265.67%-549.08%-827.91%-1512.88%-1387.88%-39.14%-1279.54%-688.50%
Effective Tax Rate
-1.84%0.30%2.85%9.23%2.04%5.49%-16.84%-0.19%-0.74%-0.09%3.77%
Return on Assets
-66.88%-78.21%-71.32%-61.25%-51.76%-58.14%-121.66%-171.92%-9.84%-38.24%-56.50%
Return On Equity
-114.73%-144.95%-126.58%-77.38%-96.76%-68.18%-176.75%-302.43%-10.97%-40.41%-87.07%
Return on Capital Employed
-104.09%-111.55%-126.64%-84.83%-96.88%-69.10%-141.49%-266.67%-10.47%-49.30%-90.85%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A3.87N/A
Quick Ratio
1.952.151.834.021.805.653.262.1910.983.612.91
Cash ratio
1.761.761.473.101.405.192.801.4310.713.612.25
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
206.10375.98334.5557.40434.73301.95451.56307.10472.35578.13246.07
Operating Cycle
206.10375.98334.5557.40434.73301.95451.56307.10472.35578.13246.07
Days of Payables Outstanding
771.97447.88597.35243.251.41K1.17K2.06K1.58K1.34K2.98K827.88
Cash Conversion Cycle
-565.86-71.90-262.8-185.85-977.78-868.53-1.61K-1.27K-877.61-2.84K-923.15
Debt Ratios
Debt Ratio
0.410.170.08N/A0.33N/A0.060.100.010.260.16
Debt Equity Ratio
0.710.310.15N/A0.61N/A0.090.170.020.360.30
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.060.100.010.04N/A
Total Debt to Capitalization
0.230.230.13N/A0.38N/A0.080.150.020.060.19
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-84.75N/A
Cash Flow to Debt Ratio
-3.36-3.74-7.59N/A-1.46N/A-14.79-14.01-9.02-9.29-0.73
Company Equity Multiplier
1.711.851.771.261.861.171.451.751.111.361.52
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-4.09-4.79-3.90-3.16-5.13-6.75-12.00-11.36-0.66-15.84-5.94
Free Cash Flow / Operating Cash Flow Ratio
1.001.121.021.091.061.011.001.001.001.061.07
Cash Flow Coverage Ratio
-3.36-3.74-7.59N/A-1.46N/A-14.79-14.01-9.02-9.29-0.73
Short Term Coverage Ratio
-3.36-3.74-7.59N/A-1.46N/A-62.52-42.91-45.62-26.65-0.73
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A